Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2013-03-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
CISC avoids urological complications in bladder with chronic and improves quality of life. Despite theses challenges, the learning of CISC can face some physical, cognitive and psychological difficulties. Recently, we have validate a new test for predicting the physical and cognitive abilities to practice CISC named "PP-Test". Meanwhile, psychological factors are not explored in this test. To our knowledge, no study has been conducted in order to demonstrate in a prospective trial, which kind of psychological barriers can exist. Likewise it would be interesting to create a new test assessing the psychological "acceptance" of the patients to CISC before learning (I-CAT). Based on the results of this self-assessment test, the specific nurse could then change her speech by playing down the importance of some fear and anxiety described by the patients. The learning of CISC would be facilitated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determinants, Impact and Adherence Related to the Duration of Performing Self Catheterization on Patient Satisfaction and Quality of Life
NCT04095871
Indwelling Urinary Catheterization Versus Clean Intermittent Catheterization for the Short-term Management of Hospitalized Patients With Transient Acute Urinary Retention
NCT02942641
Filling and Emptying Cystometries ("Backwards Cystometry"): a Feasibility and Validation Study
NCT03255421
Evaluation of Residual Urine After Intermittent Catheterisation
NCT00324233
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
NCT02616081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The final version will be validated after a feasibility study. The psychometric criteria will be validated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
Patients with dysvoiding function and chronic urinary retention, with an indication to CISC.
Intermittent catheterization test
I-CAT will be a self assessment questionnaire and a simple, comprehensive and quickly passed questionnaire.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent catheterization test
I-CAT will be a self assessment questionnaire and a simple, comprehensive and quickly passed questionnaire.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients seen in consultation or in traditional hospital
* Indication for the realization of self-catheterization Intermittent must be asked because of a bladder-type retentionist or overactive bladder with an indication of medical (anticholinergics or botulinum toxin intra-detrusor injection) or surgical (kind of expansion enterocystoplasty) treatment to prevent bladder emptying without urinary catheterization
* PP-Test score ≥10/15
* Age \> 18 years
* Patient with social security
Exclusion Criteria
* Indication to installing a suprapubic catheter or probe
* Patients able to answer to questionnaire and communicate in French
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gérard Amarenco, PU/PH
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service Neuro-Urologie
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOM 11014
Identifier Type: OTHER
Identifier Source: secondary_id
NI11029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.